Results 161 to 170 of about 12,517 (175)

Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study

Gastroenterology, 2008
Marta Martín-Llahí, Vicente Arroyo, German Soriano   +2 more
exaly  

Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome

Clinical Gastroenterology and Hepatology, 2017
, Florence Wong
exaly  

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

Journal of Hepatology, 2000
Wladimiro Jiménez, Ramon Bataller, Vicente Arroyo   +2 more
exaly  

Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: A case–control study

Digestive and Liver Disease, 2009
A Marzano
exaly  

Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study

Journal of Hepatology, 2004
Vicente Arroyo, Miquel Navasa, Père Gines   +2 more
exaly  

Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis

Digestive and Liver Disease, 2017
James Fung, Tak Mao Chan, See Ching Chan   +2 more
exaly  

Improvement in renal function in hepatorenal syndrome with N-acetylcysteine

Lancet, The, 1999
Stephen Holt, Andrew Burroughs, David Patch   +2 more
exaly  

Terlipressin for Hepatorenal Syndrome: A Meta-Analysis of Randomized Trials

International Journal of Artificial Organs, 2009
Paul Martin, Piergiorgio Messa, Vivek Dixit   +2 more
exaly  

Terlipressin and Albumin in Patients with Cirrhosis and Type I Hepatorenal Syndrome

Digestive Diseases and Sciences, 2007
Sérgio Neri, Lucia Malaguarnera, Gaetano Bertino   +2 more
exaly  

The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States

Current Medical Research and Opinion, 2017
J Bradford Rice, Khurram Jamil, Belinda Lovelace   +2 more
exaly